Actonel
Product Images NDC 0430-0471

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Actonel (NDC 0430-0471). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Allergan, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Actonel 01

FDA Label Image

Actonel 02

FDA Label Image

Actonel 03

FDA Label Image

Actonel 04

FDA Label Image

Actonel 05

FDA Label Image

Actonel 06

This appears to be a table displaying incidence percentages for patients continuing and initiating treatment with Actonel 5mg and placebo in conjunction with glucocorticoid treatment. The table shows 184 patients on Actonel 5mg continuing glucocorticoid treatment, with a 24% incidence rate. However, more context and information is needed to understand the full significance of these numbers.*

FDA Label Image

Actonel 07

This text likely represents a table or chart showing the percentage of follow-up visits for patients taking DIDRONEL 400mg and ACTONEL 30mg over a period of time. However, without more information, it is difficult to interpret the specific data presented.*

FDA Label Image

Actonel 08

Actonel 5 is a medication in the form of tablets containing alendronate sodium used as a treatment for bone diseases. The National Drug Code (NDC) for this medication is 0430-0471-15, and the package includes 30 tablets. It is recommended to dispense the enclosed medication guide to each patient before administration. This medication is only available with a prescription (Rx only).*

FDA Label Image

Actonel 09

This text is a pharmaceutical label for Actonel, a medication used to treat osteoporosis. It contains the NDC code, dosage information, and an instruction to include a medication guide with the prescription. Because there is not enough context to determine the language of the label, it is unclear whether the "fip" in "Dispense the enclosed Medication Guide fip to each patient" is a meaningful word.*

FDA Label Image

Actonel 0a

This appears to be a product label for Actonel tablets, which contain Ibandronate Sodium. The label includes information such as dosages (35mg), a National Drug Code (50229 00590) and a lot number (W34 138V1). Additionally, the label indicates that an enclosed patient information guide should be provided with each prescription.*

FDA Label Image

Actonel 0b

FDA Label Image

Actonel 0c

This appears to be a medication guide for Actone, containing instructions on how to take the tablets, including dosage and timing. It advises patients to take one tablet in the morning with plain water, before eating or drinking anything else, and to avoid lying down or taking other medications for 30 minutes afterwards. The text also mentions an enclosed medication guide that should be dispensed to each patient. The last line includes the unrelated text "Apo xy".*

FDA Label Image

Actonel 0d

FDA Label Image

Actonel 0e

This seems to be a package label for a 3 month pack of medication tablets called "Actonel" which contains 150mg of "risedronate sodium". The label includes information on how to dispense the tablets to patients along with a medication guide. There are also contact details for the manufacturer located at "201vg) AV 40 pemaes o5 0504".*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.